亚宝药业控股股东提前购回1365万股质押股份

Core Viewpoint - Yabao Pharmaceutical announced that its controlling shareholder, Yabao Investment, completed the early repurchase of 13,650,000 shares of unrestricted circulating stock through a pledged repurchase transaction on September 26, leading to the release of the corresponding pledge [1] Summary by Relevant Sections - Shareholding Structure - As of the announcement date, Yabao Investment holds 94,300,000 shares, accounting for 13.47% of the total share capital [1] - After the release of the pledge, the total pledged shares amount to 24,950,000, which represents 26.46% of Yabao Investment's total holdings and 3.56% of the company's total share capital [1] - Pledged Shares - Yabao Investment and its concerted parties collectively hold 97,300,000 shares, which is 13.90% of the total shares, with a cumulative pledge of 24,950,000 shares [1] - Company Monitoring - The company will closely monitor the pledge matters and disclose information in a timely manner [1]